{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:07:35Z","timestamp":1778108855356,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.leukres.2017.01.020","type":"journal-article","created":{"date-parts":[[2017,1,22]],"date-time":"2017-01-22T09:17:46Z","timestamp":1485076666000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The epigenetically-regulated miR-34a targeting c-SRC suppresses RAF\/MEK\/ERK signaling pathway in K-562 cells"],"prefix":"10.1016","volume":"55","author":[{"given":"Yang","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Kuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Li","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Yan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-Guo","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.leukres.2017.01.020_bib0005","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1038\/onc.2010.128","article-title":"p140Cap dual regulation of E-cadherin\/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation","volume":"29","author":"Damiano","year":"2010","journal-title":"Oncogene"},{"issue":"7006","key":"10.1016\/j.leukres.2017.01.020_bib0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"31","author":"Ambros","year":"2004","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.020_bib0015","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.devcel.2006.09.009","article-title":"The diverse functions of microRNAs in animal development and disease","volume":"11","author":"Kloosterman","year":"2006","journal-title":"Dev. Cell"},{"issue":"2","key":"10.1016\/j.leukres.2017.01.020_bib0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/leu.2013.298","article-title":"The tumor suppressor axis p53\/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients","volume":"28","author":"Boysen","year":"2014","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.leukres.2017.01.020_bib0025","doi-asserted-by":"crossref","first-page":"20459","DOI":"10.3390\/ijms141020459","article-title":"Twist and miR-34a are involved in the generation of tumor-educated myeloid-derived suppressor cells","volume":"14","author":"Wang","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.leukres.2017.01.020_bib0030","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","article-title":"Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia","volume":"27","author":"Wang","year":"2015","journal-title":"Cell. Signal."},{"issue":"36","key":"10.1016\/j.leukres.2017.01.020_bib0035","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.leukres.2017.01.020_bib0040","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/onc.2012.132","article-title":"miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme","volume":"32","author":"Yin","year":"2013","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.020_bib0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/0008-5472.CAN-15-2321","article-title":"MiR-34a silences c-SRC to attenuate tumor growth in triple-Negative Breast cancer","volume":"76","author":"Adams","year":"2016","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.leukres.2017.01.020_bib0050","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5483\/BMBRep.2013.46.6.208","article-title":"Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development","volume":"46","author":"Hao","year":"2013","journal-title":"BMB Rep."},{"issue":"3","key":"10.1016\/j.leukres.2017.01.020_bib0055","doi-asserted-by":"crossref","first-page":"e59563","DOI":"10.1371\/journal.pone.0059563","article-title":"CD24 induces expression of the oncomir miR-21 via Src, and CD24 and Src are both post-transcriptionally downregulated by the tumor suppressor miR-34a","volume":"8","author":"Muppala","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.leukres.2017.01.020_bib0060","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/carcin\/bgq033","article-title":"Epigenetic inactivation of the miR-34a in hematological malignancies","volume":"31","author":"Chim","year":"2010","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.leukres.2017.01.020_bib0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1385\/MB:32:3:197","article-title":"A novel method to monitor the expression of microRNAs","volume":"2","author":"Fu","year":"2006","journal-title":"Mol. Biotechnol."},{"issue":"10","key":"10.1016\/j.leukres.2017.01.020_bib0070","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1182\/blood-2009-02-205062","article-title":"miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53","volume":"114","author":"Navarro","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.leukres.2017.01.020_bib0075","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1124\/mol.109.063321","article-title":"MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase 1 during megakaryocytic differentiation of K562 cells","volume":"77","author":"Ichimura","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"13","key":"10.1016\/j.leukres.2017.01.020_bib0080","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2011.354","article-title":"DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer","volume":"1","author":"Lopez-Serra","year":"2012","journal-title":"Oncogene"},{"issue":"7148","key":"10.1016\/j.leukres.2017.01.020_bib0085","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","article-title":"A microRNA component of the p53 tumour suppressor network","volume":"47","author":"He","year":"2007","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.leukres.2017.01.020_bib0090","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-D","article-title":"Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line","volume":"7","author":"Law","year":"1993","journal-title":"Leuk. Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212617300206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T19:20:25Z","timestamp":1536088825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212617300206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":18,"alternative-id":["S0145212617300206"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.020","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epigenetically-regulated miR-34a targeting c-SRC suppresses RAF\/MEK\/ERK signaling pathway in K-562 cells","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}